DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Otelixizumab is an investigational drug.
There have been 5 clinical trials for Otelixizumab. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2006.
The most common disease conditions in clinical trials are Arthritis, Diabetes Mellitus, Type 1, and Diabetes Mellitus. The leading clinical trial sponsors are GlaxoSmithKline, Juvenile Diabetes Research Foundation, and [disabled in preview].
Recent Clinical Trials for Otelixizumab
|A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease||GlaxoSmithKline||Phase 2|
|Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study||GlaxoSmithKline||Phase 1|
|Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis||GlaxoSmithKline||Phase 1|